Affinity Asset Advisors, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$303.0T
Holdings
70
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (70 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | 290ACHINOOK THERAPEUTICS INC | 976,021 | $22.6T | 7.46% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 93,000 | $22.5T | 7.44% | |
| 3 | SPYSPDR S&P 500 ETF TRTR UNIT | 45,000 | $18.4T | 6.08% | Call |
| 4 | —PROMETHEUS BIOSCIENCES INC | 150,000 | $16.1T | 5.31% | |
| 5 | MRKMERCK & CO INC | 120,000 | $12.8T | 4.21% | |
| 6 | VKTXVIKING THERAPEUTICS INC | 716,149 | $11.9T | 3.94% | Put |
| 7 | BBIOBRIDGEBIO PHARMA INC | 709,800 | $11.8T | 3.88% | Put |
| 8 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,083,118 | $9.4T | 3.12% | |
| 9 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 380,000 | $9.3T | 3.06% | |
| 10 | VRNAVERONA PHARMA PLC | 452,821 | $9.1T | 3.00% | |
| 11 | VTYXVENTYX BIOSCIENCES INC | 260,008 | $8.7T | 2.87% | |
| 12 | CYTKCYTOKINETICS INC | 221,463 | $7.8T | 2.57% | |
| 13 | ESTAESTABLISHMENT LABS HLDGS INC | 113,224 | $7.7T | 2.53% | |
| 14 | AZNASTRAZENECA PLC | 110,000 | $7.6T | 2.52% | Call |
| 15 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 10,000,000 | $7.4T | 2.45% | |
| 16 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 11,000,000 | $7.1T | 2.35% | |
| 17 | CATBUSDASTRIA THERAPEUTICS INC | 529,369 | $7.0T | 2.32% | |
| 18 | BLUBELLUS HEALTH INC NEW | 881,329 | $6.3T | 2.09% | |
| 19 | ACLXARCELLX INC | 202,834 | $6.2T | 2.06% | |
| 20 | MRNAMODERNA INC | 35,000 | $5.4T | 1.77% | Call |
| 21 | MORFMORPHIC HLDG INC | 135,863 | $5.1T | 1.69% | |
| 22 | KURAKURA ONCOLOGY INC | 357,287 | $4.4T | 1.44% | |
| 23 | INZYINOZYME PHARMA INC | 751,796 | $4.3T | 1.42% | |
| 24 | ASNDASCENDIS PHARMA A/S | 40,000 | $4.3T | 1.42% | |
| 25 | SGENUSDSEAGEN INC | 20,000 | $4.0T | 1.34% | |
| 26 | ARGXARGENX SE | 10,750 | $4.0T | 1.32% | |
| 27 | ETNBGBP89BIO INC | 236,200 | $3.6T | 1.19% | Call |
| 28 | XENEXENON PHARMACEUTICALS INC | 90,000 | $3.2T | 1.06% | |
| 29 | ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE | 7,500,000 | $3.0T | 0.99% | |
| 30 | CNTACENTESSA PHARMACEUTICALS PLC | 684,127 | $2.6T | 0.87% | |
| 31 | VRDNVIRIDIAN THERAPEUTICS INC | 100,500 | $2.6T | 0.84% | Call |
| 32 | LNTHLANTHEUS HLDGS INC | 30,244 | $2.5T | 0.82% | |
| 33 | BMRNBIOMARIN PHARMACEUTICAL INC | 25,000 | $2.4T | 0.80% | |
| 34 | NVV1NOVAVAX INC | 346,800 | $2.4T | 0.79% | Put |
| 35 | PCVXVAXCYTE INC | 62,223 | $2.3T | 0.77% | |
| 36 | APLSAPELLIS PHARMACEUTICALS INC | 35,000 | $2.3T | 0.76% | |
| 37 | MIRMMIRUM PHARMACEUTICALS INC | 95,000 | $2.3T | 0.75% | |
| 38 | KRTXKARUNA THERAPEUTICS INC | 12,500 | $2.3T | 0.75% | |
| 39 | HZNPHORIZON THERAPEUTICS PUB L | 20,000 | $2.2T | 0.72% | |
| 40 | NVLSEURALPINE IMMUNE SCIENCES INC | 247,891 | $1.9T | 0.63% | |
| 41 | TCE2CELLDEX THERAPEUTICS INC NEW | 50,000 | $1.8T | 0.59% | |
| 42 | KPTIEURKARYOPHARM THERAPEUTICS INC | 460,979 | $1.8T | 0.59% | |
| 43 | KALVKALVISTA PHARMACEUTICALS INC | 208,292 | $1.6T | 0.54% | |
| 44 | —VINCERX PHARMA INC | 1,492,771 | $1.6T | 0.51% | |
| 45 | COGTCOGENT BIOSCIENCES INC | 143,064 | $1.5T | 0.51% | |
| 46 | —PRECIGEN INC | 1,500,000 | $1.5T | 0.48% | |
| 47 | NRIXNURIX THERAPEUTICS INC | 150,000 | $1.3T | 0.44% | |
| 48 | LIANYLIANBIO | 650,000 | $1.3T | 0.42% | |
| 49 | NARIUSDINARI MED INC | 20,000 | $1.2T | 0.41% | |
| 50 | ADCTADC THERAPEUTICS SA | 600,000 | $1.2T | 0.39% | |
| 51 | —POINT BIOPHARMA GLOBAL INC | 149,586 | $1.1T | 0.36% | |
| 52 | ACRSACLARIS THERAPEUTICS INC | 129,100 | $1.0T | 0.34% | Call |
| 53 | MLYSMINERALYS THERAPEUTICS INC | 62,500 | $978.8B | 0.32% | |
| 54 | —THESEUS PHARMACEUTICALS INC | 98,221 | $872.2B | 0.29% | |
| 55 | BCABBIOATLA INC | 325,000 | $871.0B | 0.29% | |
| 56 | JSPRJASPER THERAPEUTICS INC | 476,948 | $863.3B | 0.28% | |
| 57 | FHTXFOGHORN THERAPEUTICS INC | 136,771 | $848.0B | 0.28% | |
| 58 | MISTMILESTONE PHARMACEUTICALS IN | 199,382 | $785.6B | 0.26% | |
| 59 | ROIVROIVANT SCIENCES LTD | 100,000 | $738.0B | 0.24% | |
| 60 | ESPRESPERION THERAPEUTICS INC NE | 350,000 | $556.5B | 0.18% | Put |
| 61 | PBYIPUMA BIOTECHNOLOGY INC | 177,349 | $548.0B | 0.18% | |
| 62 | —NLS PHARMACEUTICS LTD | 344,089 | $519.6B | 0.17% | |
| 63 | NUVBNUVATION BIO INC | 250,000 | $415.0B | 0.14% | |
| 64 | GLYCEURGLYCOMIMETICS INC | 300,000 | $378.0B | 0.12% | Put |
| 65 | PIRSPIERIS PHARMACEUTICALS INC | 306,950 | $299.6B | 0.10% | |
| 66 | IMTXIMMATICS N.V | 187,204 | $269.6B | 0.09% | |
| 67 | NAMSNEWAMSTERDAM PHARMA COMPANY | 37,000 | $68.5B | 0.02% | |
| 68 | SCLXWSCILEX HOLDING CO | 18,099 | $19.0B | 0.01% | |
| 69 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $12.3B | 0.00% | |
| 70 | SCLXUSDSCILEX HOLDING CO | 463 | $3.8B | 0.00% |